James T. Kenney, RPh, MBA

Manager
Specialty and Pharmacy Contracts
Harvard Pilgrim Health Care
Boston, MA

Authored Items

Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States

Kathleen F. Villa, MS, James T. Kenney, RPh, MBA, Nancy L. Reaven, MA, Susan E. Funk, MBA, Karen McGaughey, PhD, Jed Black, MD

May 2018 Vol 11, No 3 in Business, Original Research

Prospective Bundled Payments in a Changing Environment: The Experience of a Self-Funded, State-Sponsored Plan

Frank H. Lawler, MD, MSPH, James T. Kenney, RPh, MBA, Frank R. Wilson, CPA, G. Keith Smith, MD, Lynn V. Mitchell, MD, MPH

December 2017 Vol 10, No 9 in Original Research

The Cost of Hematopoietic Stem-Cell Transplantation in the United States

Michael S. Broder, MD, MSHS, Tiffany P. Quock, PhD, MS, Eunice Chang, PhD, Sheila R. Reddy, PhD, RPh, James T. Kenney, RPh, MBA, Rajni Agarwal-Hashmi, MD, Sally Arai, MD, Kathleen F. Villa, MS

October 2017 Vol 10, No 7 in Business, Original Research

The Medical and Economic Burden of Narcolepsy: Implications for Managed Care

Michael J. Thorpy, MB, ChB, George Hiller, RPh, James T. Kenney, RPh, MBA

July 2017 Vol 10, No 5 in Clinical

Does a Free Office Visit Affect Primary Care–Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi

James T. Kenney, RPh, MBA, Bettina M. Beech, DrPH, MPH, Tristan Cordier, MS, Laura E. Happe, PharmD, MPH, Laura Trunk, MD, Gilbert S. Haugh, MS, Richard Kwong, MPH, Vipin Gopal, PhD, Roy A. Beveridge, MD

April 2017 Vol 10, No 2 in Business, Original Research

Health Plans Must Monitor the Oncology Pipeline to Apply Appropriate Coverage Criteria, Maintain Treatment Value

James T. Kenney, RPh, MBA

February 2017 Vol 10, Special Issue: Payers’ Perspectives In Oncology: ASH 2016 Highlights in Payers' Perspectives

The Challenge of Balancing Access to and Paying for New, High-Cost Cancer Therapies

James T. Kenney, RPh, MBA, James T. Kenney, RPh, MBA

August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology in Payers' Perspectives

Value-Based Care Must Be Linked to Improved Clinical Outcomes

James T. Kenney, RPh, MBA

February 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology

Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework

James T. Kenney, RPh, MBA, Anuja Roy, PhD, MBA, Jonathan K. Kish, PhD, MPH, Lisa Bloudek, PharmD, MS, David S. Siegel, MD, PhD, Sundar Jagannath, MD, Denise Globe, PhD, Emil T. Kuriakose, MD, Kristen Migliaccio-Walle, BS

June 2015, Vol 8, No 4 in Business

Utilization of Parenteral Anticoagulants and Warfarin: Impact on the Risk of Venous Thromboembolism Recurrence in the Outpatient Setting

Jennifer Cai, MS, MPH, Winghan Jacqueline Kwong, PharmD, PhD, Ronald Preblick, PharmD, MPH, Qiaoyi Zhang, MD, PhD, James T. Kenney, RPh, MBA

November 2014 Vol 7, No 8 in Clinical

The Health and Economic Effects of Counterfeit Drugs

Erwin A. Blackstone, PhD, Joseph P. Fuhr, Jr, PhD, Steve Pociask, MA, James T. Kenney, RPh, MBA

June 2014 Vol 7, No 4 in Business

Payers’ Management of Oncology Drugs: Opportunities and Challenges

James T. Kenney, RPh, MBA

May 2014 Vol 7, No 3 in Perspectives

Increasing Importance of Oncology Drug Management for Payers

James T. Kenney, RPh, MBA

July 2013 Vol 6, No 5 in Editorial

Curbing the Costly Trend: Exploring the Need for a Progressive Approach to the Management of Specialty Pharmaceuticals Under the Medical Benefit

Michael S. Jacobs, RPh, James T. Kenney, RPh, MBA, Kjel A. Johnson, PharmD, BcPS, FccP, FAMcP

July/August 2012, Vol 5, No 5 in Business

Impact of the Removal of the Monthly Liver Function Test Requirement for Ambrisentan

Louise A. Durst, RN, James T. Kenney, RPh, MBA, John Carlsen, MHA, Megan Kuchinski, MPH, Lauren Harner, JD, Daniel Neves, BA, Stephanie J. Harris, RN, BSN, Glenna L. Traiger, RN, MSN, CNS-BC

March/April 2012, Vol 5, No 2 in Business

A Call to Action: Responding to the Future Forecasting of Cardiovascular Disease in America

Robert Lee Page ii, PharmD, MSPH, FAHA, FCCP, FASCcP, FASHP, BCPS, Vahram Ghushchyan, PhD, Kavita Nair, PhD, James T. Kenney, RPh, MBA

September 2011, Vol 4, No 5 in Clinical

A Wellness-Based Healthcare System for Chronic Diseases: Prevention, Intervention, and Innovation

Robert E. Henry, Kip Piper, MA, FACHE, F. Randy Vogenberg, RPh, PhD, Thomas McCarter, MD, FACP, Farrah N. Daly, MD, MBA, Keri Cooper, Nirav R. Shah, MD,MPH, Lawton Robert Burns, PhD, MBA, Gene Reeder, RPh, PhD, Scott Gottlieb, MD, Toni Fera, BPharm, PharmD, Wayne M. Lednar, MD, PhD, Alberto M. Colombi, MD, MPH, Michael F. Murphy, MD, PhD, Gary M. Owens, MD, James T. Kenney, RPh, MBA, J. B. Jones, PhD, MBA, Walter F. Stewart, PhD, MPH

Supplements

Last modified: January 25, 2018

• 
• 
• 

• 
• 
• 

• 
•